Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-08-16 Purchase | 2024-08-20 4:04 pm | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Director | 3,173 | $7.88 | $25,003 | 224,524 (Indirect Direct) | View |
2024-01-23 Sale | 2024-01-25 6:24 pm | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 35,000 | $24.98 | $874,200 | 638,449 (Indirect Direct) | View |
2023-12-04 Sale | 2023-12-06 5:18 pm | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 20,000 | $20.76 | $415,200 | 170,559 (Direct) | View |
2021-11-15 Sale | 2021-11-17 5:03 pm | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO | 10,000 | $20.15 | $201,480 | 103,546 (Direct) | View |
2020-03-10 Purchase | 2020-03-11 08:40 am | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO | 98,000 | $1.0615 | $104,027 | 574,800 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-07-26 Gift | 2024-07-26 4:47 pm | N/A 2030-02-28 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Director | 262,574 | $0 | 1,045,966 (Direct) | View |
2024-07-10 Exercise | 2024-07-12 5:03 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 11,111 | $0 | 243,574 (Direct) | View |
2024-05-31 Option Award | 2024-06-04 4:56 pm | 2025-05-31 N/A | Alkermes plc. | ALKS | Lurker Nancy Director | 25,505 | $0 | 25,505 (Direct) | View |
2024-04-11 Option Award | 2024-04-12 4:16 pm | 2025-04-11 N/A | Alkermes plc. | ALKS | Lurker Nancy Director | 40,514 | $0 | 40,514 (Direct) | View |
2024-02-09 Exercise | 2024-02-13 5:40 pm | N/A 2031-02-09 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 37,534 | $0 | 758,740 (Direct) | View |
2024-02-09 Tax Withholding | 2024-02-13 5:40 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 14,943 | $28.8 | 758,740 (Direct) | View |
2024-02-13 Gift | 2024-02-13 5:40 pm | N/A 2030-02-28 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 99,817 | $0 | 758,740 (Direct) | View |
2024-01-24 Gift | 2024-01-25 6:24 pm | N/A 2033-01-05 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 225,400 | $0 | 638,449 (Direct) | View |
2024-01-05 Option Award | 2024-01-09 9:17 pm | N/A 2034-01-05 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 115,000 | $0 | 435,708 (Direct) | View |
2024-01-06 Tax Withholding | 2024-01-09 9:17 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 23,043 | $20.4 | 435,708 (Direct) | View |
2024-01-06 Exercise | 2024-01-09 9:17 pm | N/A 2033-06-19 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 75,133 | $0 | 435,708 (Direct) | View |
2023-12-28 Gift(A) | 2024-01-03 6:37 pm | N/A 2031-02-09 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 206,348 | $0 | 699,059 (Direct) | View |
2023-12-28 Gift | 2024-01-02 5:41 pm | N/A 2031-02-09 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 154,140 | $0 | 528,500 (Direct) | View |
2023-07-10 Option Award | 2023-07-12 6:52 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 100,000 | $0 | 100,000 (Direct) | View |
2023-06-20 Option Award | 2023-06-22 09:14 am | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy CEO | 225,400 | $0 | 225,400 (Direct) | View |
2023-05-11 Gift | 2023-05-15 6:15 pm | N/A 2026-09-15 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy CEO | 771,088 | $0 | 784,500 (Direct) | View |
2023-02-09 Exercise | 2023-02-13 4:56 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy CEO | 37,533 | $0 | 248,093 (Direct) | View |
2023-01-06 Option Award | 2023-01-10 5:58 pm | N/A 2033-01-05 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy CEO | 450,800 | $0 | 450,800 (Direct) | View |
2022-02-28 Exercise | 2022-03-02 6:21 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO | 12,466 | $0 | 150,281 (Direct) | View |
2022-02-21 Exercise | 2022-02-23 4:13 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO | 13,717 | $0 | 151,533 (Direct) | View |
2022-02-09 Option Award | 2022-02-11 4:38 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO | 300,000 | $0 | 459,165 (Direct) | View |
2022-02-09 Exercise | 2022-02-11 4:38 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO | 17,533 | $0 | 459,165 (Direct) | View |
2021-06-22 Option Award | 2021-06-23 5:27 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO | 266,300 | $0 | 266,300 (Direct) | View |
2021-06-15 Option Award | 2021-06-17 6:51 pm | 2022-06-15 2031-06-15 | Aquestive Therapeutics Inc. | AQST | Lurker Nancy Director | 20,000 | $0 | 20,000 (Direct) | View |
2021-06-14 Exercise | 2021-06-15 5:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO | 4,500 | $0 | 113,546 (Direct) | View |
2021-02-28 Exercise | 2021-03-02 7:21 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO | 12,467 | $0 | 121,512 (Direct) | View |
2021-02-21 Exercise | 2021-02-23 9:01 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO | 13,717 | $0 | 110,297 (Direct) | View |
2020-06-15 Ownership | 2021-02-11 4:05 pm | N/A 2026-09-15 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy See Remarks | 249,764 | $0 | 256,000 (Direct) | View |
2020-06-30 Exercise | 2020-07-02 6:13 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO | 124,667 | $0 | 1,033,800 (Direct) | View |
2020-06-27 Exercise | 2020-06-30 7:40 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO | 40,000 | $0 | 659,800 (Direct) | View |
2020-06-16 Option Award | 2020-06-18 4:05 pm | 2021-06-16 2030-06-16 | Aquestive Therapeutics Inc. | AQST | Lurker Nancy Director | 14,000 | $0 | 14,000 (Direct) | View |
2020-06-14 Exercise | 2020-06-16 5:03 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO | 45,000 | $0 | 664,800 (Direct) | View |
2020-02-28 Option Award | 2020-03-03 5:56 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO | 1,122,000 | $0 | 1,122,000 (Direct) | View |
2020-02-21 Exercise | 2020-02-25 4:50 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy President & CEO | 137,174 | $0 | 751,149 (Direct) | View |